A: You can download an enrollment form from this Website, complete your portion, and bring the form to your doctor. He or she will complete and submit the form, and then a Coverage Plus representative will call you.

A: You will need to visit your doctor. If he or she decides to prescribe the medication, the doctor can complete and submit an enrollment form.

A: VCPP does answer questions about treatment with SYPRINE®.

A: Contact the VCPP by telephone at 888-607-7267. Coverage Plus representatives are available to assist you from 8:00 AM–6:00 PM ET Monday through Friday.

A: If you are calling outside of normal business hours, please leave your name, number, and a message so that one of the VCPP representatives can return your phone call the next business day.

A: Yes. Some reasons to get in touch with the VCPP include changing the mailing address for SYPRINE® shipments, reporting shipping-related damage or delays, or updating co-payment arrangements.

A: Yes. Some reasons to get in touch with the VCPP include changing the prescription dose or patient instructions.

A: Contact the VCPP, explain the situation, and ask for assistance.

A: Once the VCPP starts sending you SYPRINE®, they will also send the claim to your insurance company.

A: No. Once you are enrolled in the program, you have the option of authorizing the VCPP to automatically send you SYPRINE® every month until or unless you contact the VCPP to notify them that your therapy is stopping. Re-enrollment takes place at the beginning of each calendar year.

A: Just call the VCPP and we will contact your local pharmacy to arrange transfer of the prescription.

A: Patients ineligible for the VCPP include those enrolled in Medicare, Medicaid, TRICARE, Veterans Administration or Department of Defense, the Indian Health Service, or any other federally or state-funded healthcare program, or where prohibited by law, or whose commercial healthcare insurance providers prohibit the use of select specialty pharmacies. For more information, call a VCPP representative at 888-607-7267.

INDICATIONS AND USAGE
Syprine® (trientine hydrochloride) is used to treat Wilson's disease in patients who cannot take the medication known as penicillamine. Wilson's disease is a condition where the body stores too much copper. Syprine is not recommended to treat cystinuria (a condition where a protein known as cystine is excreted into the urine), rheumatoid arthritis, or a disease affecting the bile ducts in the liver known as biliary cirrhosis.
IMPORTANT SAFETY INFORMATION
  • Do not take Syprine if you are allergic to it or any parts of the formulation.
  • You should remain under regular medical supervision the entire time you are taking Syprine. Your doctor should regularly check to see if you have iron deficiency anemia. This is particularly important for women.
  • Take Syprine on an empty stomach, at least one hour before a meal or two hours after a meal and at least one hour apart from any other drug, food, or milk. The capsules should be swallowed whole with water and should not be opened or chewed. For the first month of treatment, take your temperature every night, and report any symptom such as fever or skin rash to your doctor.
  • Tell your doctor if you are pregnant, plan to become pregnant, or are nursing.
  • The following adverse reactions have been reported from a clinical study: iron deficiency and a condition affecting the immune system known as systemic lupus erythematosus. In addition, the following adverse reactions have been reported in marketed use: abnormal or uncontrolled muscle contractions, muscle spasm and an immune disease affecting muscles known as myasthenia gravis.
  • Do not take mineral supplements because they may block the absorption of Syprine.
Please click here to see full Prescribing Information for Syprine Capsules.
You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

©2016 Valeant Pharmaceuticals North America LLC. All Rights Reserved. SYP.0024.USA.16

 

Indications and Usage

Syprine® (trientine hydrochloride) is used to treat Wilson's disease in patients who cannot take the medication known as penicillamine. Wilson's disease is a condition where the body stores too much copper. Syprine is not recommended to treat cystinuria (a condition where a protein known as cystine is excreted into the urine), rheumatoid arthritis, or a disease affecting the bile ducts in the liver known as biliary cirrhosis.

Important Safety Information

  • Do not take Syprine if you are allergic to it or any parts of the formulation.
  • You should remain under regular medical supervision the entire time you are taking Syprine. Your doctor should regularly check to see if you have iron deficiency anemia. This is particularly important for women.
  • Take Syprine on an empty stomach, at least one hour before a meal or two hours after a meal and at least one hour apart from any other drug, food, or milk. The capsules should be swallowed whole with water and should not be opened or chewed. For the first month of treatment, take your temperature every night, and report any symptom such as fever or skin rash to your doctor.
  • Tell your doctor if you are pregnant, plan to become pregnant, or are nursing.
  • The following adverse reactions have been reported from a clinical study: iron deficiency and a condition affecting the immune system known as systemic lupus erythematosus. In addition, the following adverse reactions have been reported in marketed use: abnormal or uncontrolled muscle contractions, muscle spasm and an immune disease affecting muscles known as myasthenia gravis.
  • Do not take mineral supplements because they may block the absorption of Syprine.
Please click here to see full Prescribing Information for Syprine Capsules.
 

INDICATIONS AND USAGE

Syprine® (trientine hydrochloride) is used to treat Wilson's disease in patients who cannot take the medication known as penicillamine. Wilson's disease is a condition where the body stores too much copper. SYPRINE® is not recommended to treat cystinuria (a condition where a protein known as cystine is excreted into the urine), rheumatoid arthritis, or a disease affecting the bile ducts in the liver known as biliary cirrhosis.

IMPORTANT SAFETY INFORMATION

  • Do not take Syprine if you are allergic to it or any parts of the formulation.
  • You should remain under regular medical supervision the entire time you are taking Syprine. Your doctor should regularly check to see if you have iron deficiency anemia. This is particularly important for women.
  • Take Syprine on an empty stomach, at least one hour before a meal or two hours after a meal and at least one hour apart from any other drug, food, or milk. The capsules should be swallowed whole with water and should not be opened or chewed. For the first month of treatment, take your temperature every night, and report any symptom such as fever or skin rash to your doctor.
  • Tell your doctor if you are pregnant, plan to become pregnant, or are nursing.
  • The following adverse reactions have been reported from a clinical study: iron deficiency and a condition affecting the immune system known as systemic lupus erythematosus. In addition, the following adverse reactions have been reported in marketed use: abnormal or uncontrolled muscle contractions, muscle spasm and an immune disease affecting muscles known as myasthenia gravis.
  • Do not take mineral supplements because they may block the absorption of Syprine.
Please click here to see full Prescribing Information for Syprine Capsules.